MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Suicidality in Parkinson’s Disease: A Case Control Study

M. Akbostanci, E. Bayram, D. Sayar, T. Ayidaga (Ankara, Turkey)

Meeting: 2017 International Congress

Abstract Number: 1084

Keywords: Depression, Parkinsonism

Session Information

Date: Wednesday, June 7, 2017

Session Title: Parkinson's Disease: Psychiatric Manifestations

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To investigate suicidality in Parkinson’s disease (PD) by a case control study

Background: Depression, a risk factor for suicidality, is rather common in PD patients. Nevertheless, a small number of clinical studies report conflicting data on suicidality in Parkinson’s disease (PD). In addition, to the best of our knowledge, this is the first study to investigate suicidal ideation in a case control manner.

Methods: One hundred PD patients, and 100 age-, sex-, years of education-, and marital status- matched healthy controls (HCs) were included. Cognitive impairment was assessed by Mini Mental State Examination (MMSE) and participants with a score <24 were excluded.  Beck Depression Inventory (BDI) and Suicide Probability Scale (SPS) were filled by each participant. For PD group, data on disease duration, Hoehn-Yahr stages (HYS), levodopa equivalent daily doses (LEDD), and whether they had subthalamic deep brain stimulation (DBS) or not were obtained. As data were not normally distributed, nonparametric analyses were used.

Results: All data are reported as mean (standard deviation) or number (percentage). Suicide Probability Scale score was significantly lower in PD group (56,6 (+-12,9) vs 63,9 (+-13,5) U=3367.5, p<.01), lower score meaning lower suicidality. Demographics and scale scores of each study group are summarized in Table 1. Disease features of PD group are summarized in Table 2. 

[table1]

[table2]

Healthy controls had a significantly higher MMSE score. Although SPS scores were significantly lower in PD patients both groups had similar BDI scores. Suicide Probability Scale had a moderate positive relationship with BDI and a very weak negative relationship with MMSE (rs=.515 p<.01; rs=-.142, p=.045).  For PD group, SPS had weak positive relationships with disease duration and LEDD (rs=.219 p=.037; rs=-.213, p=.033). Although MMSE and BDI scores were similar in between different HYS (X2 (5) = 8.787, p=.118; X2 (5) = 3.569, p=.613), SPS scores were significantly different (X2 (5) =11 .983, p=.035) (Figure 1). Nevertheless; MMSE, BDI and SPS were not affected by DBS (U=708, p=.784; U=735, p=.978; U=544.5, p=.082).

[figure1]

Conclusions: Suicidality is lower in PD compared to healthy controls. Depression is a risk factor and disease severity increases suicidality in PD.

To cite this abstract in AMA style:

M. Akbostanci, E. Bayram, D. Sayar, T. Ayidaga. Suicidality in Parkinson’s Disease: A Case Control Study [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/suicidality-in-parkinsons-disease-a-case-control-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/suicidality-in-parkinsons-disease-a-case-control-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley